million people affected worldwide
Psychedelic research currently is in Not Applicable
If psychedelics are to become medicines at scale, the economics of the treatments do need to work. By work, I mean they will need to be cost-effective to a point that insurers are willing to provide the funds for them. Private (non-medical or non-insured) use will certainly have a place, but the real impact will be realised when psychedelics become part of mainstream healthcare.
This topic page is linked to our papers but doesn’t yet have a full explanation.
These are the institutes, from companies to universities, who are working on Economics.
These are some of the best-known people, from researchers to entrepreneurs, working on Economics.
Linked Research Papers & Trials
Pro & Business members will be able to see all linked papers and trials directly on this topic page.
See the information directly on this page with a paid membership.